Latest information on giritinib medical insurance in 2024
Gilteritinib, a protein kinase inhibitor with gilteritinib as its core active ingredient, has emerged in the treatment of acute myeloid leukemia (AML). Especially for patients with AML caused by FLT3 gene mutations, giritinib, with its unique efficacy, has brought new hope to many patients with relapse or poor treatment. By precisely regulating the abnormal activity of the FLT3 gene, giritinib effectively inhibits the proliferation of leukemia cells and opens up a new treatment path for AML patients. However, the high cost of treatment has always been an obstacle to the popularization of giritinib, and many patients and families are under tremendous financial pressure as a result. Changes in medical insurance policies have become the focus of attention of patients and the medical community.

As of now, giritinib has not been included in the medical insurance catalog, but as time goes by, the possibility of its inclusion in medical insurance gradually increases. Once giritinib enters medical insurance, its price will be more reasonably regulated, thereby providing an accessible treatment option for more patients.
At the same time, in addition to the original drug, generic drugs of giritinib are already available in overseas markets. These generic drugs are relatively more affordable and provide new treatment options for patients with limited economic conditions. For example, each box of the Lucius version of generic medicine is 40mg*90 tablets, and a box sells for about 3,000 yuan. There is also a version produced by Daxiong Pharmaceutical Factory, each box has a specification of 40mg*84 tablets, and the price is about more than 4,000 yuan. However, there are certain risks involved in purchasing drugs overseas. Patients and their families need to be cautious when choosing and ensure that they choose formal channels to ensure the safety and effectiveness of medication.
Regardless of whether they choose original drugs or generic drugs, patients should use them under the guidance of a professional doctor. This drug is a prescription drug. Make sure it meets the treatment needs of your current medical condition to ensure that it is safe and effective.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)